Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 85-89, April 2010

Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval

  • Caroline J. Breitbach

      Affiliations

    • Jennerex Inc., San Francisco, CA, USA
    • ,
  • Tony Reid

      Affiliations

    • University of California, San Diego Cancer Center, La Jolla, CA, USA
    • ,
  • James Burke

      Affiliations

    • Billings Clinic, Billings, MT, USA
    • ,
  • John C. Bell

      Affiliations

    • Jennerex Inc., San Francisco, CA, USA
    • Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
    • Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada
    • ,
  • David H. Kirn

      Affiliations

    • Jennerex Inc., San Francisco, CA, USA
    • Corresponding Author InformationCorresponding author at: Jennerex Inc. 201 Mission Suite 1380, San Francisco, CA 94105, USA.

published online 18 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1359-6101(10)00012-2

doi:10.1016/j.cytogfr.2010.02.001

Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 85-89, April 2010

Article Tools

* Image Usage & Resolution